摘要
目的观察阿魏酸钠联合苯磺酸氨氯地平对原发性高血压的治疗效果。方法将98例原发性高血压患者随机分为治疗组与对照组,每组各49例,对照组患者给予苯磺酸氨氯地平进行治疗,5mg/d,顿服;治疗组患者加服阿魏酸钠,100mg/次,3次/d;2组治疗周期均为8周,治疗结束后评定疗效。结果治疗组临床疗效及肾功能保护作用均显著优于对照组,差异均具有统计学意义(P<0.05)。结论阿魏酸钠联合苯磺酸氨氯地平治疗原发性高血压的疗效显著,值得在临床推广使用。
Objective To observe the therapeutic efficacy of sodium ferulate combined amlodipine besylate on patients with essential hypretension.Methods 98 patients with essential hypretension were randomly divided into treatment group（n=49,treated with andodipine besylate） and control group（n=49 ,treated with sodium ferulate combined amlodipine besylate）.The therapeutic efficacy were observed and compared after 8 weeks.Results The therapeutic efficacy and renal protective effects of the treatment group were significantly superior than those of the control group,the differences were statistically significant（P〈0.05）.Conclusion The treatment of sodium ferulate Combined amlodipine besylate has definite therapeutic efficacy on patients with essential hypertension,and is feasible in clinical application.
出处
《中外医疗》
2012年第4期20-21,共2页
China & Foreign Medical Treatment
关键词
苯磺酸氨氯地平
阿魏酸钠
原发性高血压
疗效
Amlodipine besylate
Sodium ferulate I Essential hypertension
Therapeutic efficacy
